SCHEMBL537780

SCHEMBL537780

COC(=O)CCN(Cc1ccccc1)c1nc(C)nc(Cl)c1C(O)=S

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ CYP11B1 P15538 1/20 0.35
▸ CYP11B2 P19099 1/20 0.35
▸ TAAR1 Q96RJ0 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HTT P42858 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ CRHR1 P34998 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL537779 0.79 PPARG (0.44) TDP1ALDH1A1MEN1KMT2ANPC1
SCHEMBL13131434 0.77 PPARG (0.43) TDP1ALDH1A1KMT2ANPC1RAB9A
SCHEMBL537640 0.71 PPARG (0.42) TDP1ALDH1A1KMT2ANPC1RAB9A
SCHEMBL13145998 0.69 PPARG (0.45) TDP1ALDH1A1KMT2ANPC1RAB9A
SCHEMBL19893486 0.69 TDP1 (0.42) TDP1ALDH1A1MEN1KMT2ANPC1
SCHEMBL19893050 0.69 AGTR1 (0.43) TDP1ALDH1A1MEN1KMT2ANPC1
SCHEMBL5175327 0.68 TDP1 (0.54) TDP1ALDH1A1MEN1KMT2ANPC1
SCHEMBL3258895 0.68 TDP1 (0.54) TDP1ALDH1A1NPC1RAB9AKDM4E
SCHEMBL19893347 0.67 ALDH1A1 (0.43) TDP1ALDH1A1MEN1KMT2AKDM4E
SCHEMBL6555102 0.67 TDP1 (0.46) TDP1ALDH1A1NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 — — US disclosed
EP-2414359-A1 PERI-FUSED PYRAZOLO-PYRIMIDINE COMPOUNDS ArQule, Inc. (US) 2012-02-08 — — EP disclosed
WO-2010114905-A1 PERI-FUSED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-10-07 — — WO disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 TDP1 293/4885ALDH1A1 924/4885MEN1 1767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback